Procter & Gamble (NYSE:PG) Price Target Cut to $171.00

Procter & Gamble (NYSE:PGGet Free Report) had its target price reduced by investment analysts at Deutsche Bank Aktiengesellschaft from $172.00 to $171.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 5.88% from the stock’s previous close.

PG has been the subject of a number of other research reports. UBS Group raised their price objective on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Barclays raised their price objective on shares of Procter & Gamble from $165.00 to $168.00 and gave the stock an “overweight” rating in a research note on Friday, April 12th. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Royal Bank of Canada raised their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 24th. Finally, Jefferies Financial Group raised their price objective on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $168.88.

View Our Latest Report on PG

Procter & Gamble Trading Up 0.6 %

Procter & Gamble stock opened at $161.50 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.48 and a current ratio of 0.69. The firm has a market cap of $380.01 billion, a price-to-earnings ratio of 26.39, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. Procter & Gamble has a 1 year low of $141.45 and a 1 year high of $163.14. The firm’s 50 day moving average price is $159.32 and its two-hundred day moving average price is $153.26.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.77%. The firm’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.37 earnings per share. On average, research analysts predict that Procter & Gamble will post 6.53 EPS for the current fiscal year.

Insider Activity at Procter & Gamble

In related news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $151,788. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of the business’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $151,788. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. In the last 90 days, insiders sold 103,771 shares of company stock valued at $16,292,467. Insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of PG. Advantage Trust Co acquired a new position in Procter & Gamble during the 4th quarter worth $28,000. Wyrmwood Management LLC acquired a new position in shares of Procter & Gamble during the fourth quarter valued at about $29,000. Naples Money Management LLC acquired a new position in shares of Procter & Gamble during the fourth quarter valued at about $29,000. Transcendent Capital Group LLC acquired a new position in shares of Procter & Gamble during the fourth quarter valued at about $31,000. Finally, Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble during the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.